Dice CEO: Energy, T...
Health Care: Drugs
Enzon Pharmaceuticals Inc. (ENZN: NASDAQ)
$6.41 -0.02 | -0.31%
06/01/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 104.32M | 397.53M | 50.44M | 79.71M |
| Receivables | 0.00 | 0.00 | 15.70M | 11.69M |
| Inventories | 0.00 | 0.00 | 17.73M | 16.27M |
| Other Current Assets | 2.75M | 5.92M | 7.67M | 5.28M |
| Total Current Assets | 165.26M | 434.62M | 145.21M | 178.14M |
| Property, Plant & Equipment, Gross | 57.38M | 59.86M | 86.99M | 84.30M |
| Accumulated Depreciation & Depletion | 40.57M | 38.29M | 47.76M | 39.71M |
| Property, Plant & Equipment, Net | 16.80M | 21.57M | 39.24M | 44.58M |
| Intangibles | 0.00 | 0.00 | 49.80M | 60.65M |
| Other Non-Current Assets | 161.15M | 32.67M | 98.50M | 65.87M |
| Total Non-Current Assets | 177.95M | 54.24M | 187.54M | 171.11M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 343.21M | 488.86M | 332.75M | 349.25M |
| Accounts Payable | 1.57M | 4.19M | 4.26M | 4.44M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 6.52M |
| Total Current Liabilities | 15.26M | 18.39M | 25.00M | 36.09M |
| Long Term Debt | 129.50M | 134.50M | 250.05M | 267.55M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 1.26M | 4.11M | 4.42M | 3.95M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 130.76M | 138.61M | 254.47M | 271.50M |
| Total Liabilities | 146.03M | 157.00M | 279.47M | 307.59M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 197.18M | 331.86M | 53.28M | 41.66M |
| Common Par | 483.00K | 588.00K | 453.00K | 450.00K |
| Additional Paid In Capital | 341.76M | 454.66M | 352.05M | 345.09M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -145.06M | -124.30M | -301.54M | -302.23M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 3.00K | 914.00K | 2.33M | -1.65M |
| Total Capitalization | 326.68M | 466.36M | 303.33M | 309.21M |
| Total Equity | 197.18M | 331.86M | 53.28M | 41.66M |
| Total Liabilities & Stock Equity | 343.21M | 488.86M | 332.75M | 349.25M |
| Total Common Shares Outstanding | 48.29M | 58.82M | 45.26M | 45.03M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 51.91M | 58.47M | 45.19M | 44.40M |
| Diluted Weighted Shares Outstanding | 51.91M | 58.47M | 45.75M | 44.40M |
| Number of Employees | 72 | 126 | 317 | 351 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ENZN
- Portfolio NameUser Type
- ProSeth Klarman - Baupost Group
- ProCarl Icahn
- UserGFNN Stockdiagnostics 12
- UserVermonty #1
- ProRichard Perry - Perry Capital
- ProMichael Price - MFP Investors
- UserInternational Value Fund
- UserRichard_stocks
- ContributorBarron's Activist Stocks 5-...
- UserASCO 2010 Part 2
Latest ENZN Headlines from TheStreet
- Enzon Pharmaceuticals Inc. (ENZN): Today's Featured Drugs Loser 10.05.11 | 04:10 pm
- Enzon Stock Hits New 52-Week Low (ENZN) 09.30.11 | 03:09 pm
- Enzon Stock Hits New 52-Week Low (ENZN) 09.22.11 | 02:09 pm
- Enzon Pharmaceuticals Inc. Stock Downgraded (ENZN) 08.09.11 | 07:08 am
- Enzon Stock Hits New 52-Week Low (ENZN) 08.04.11 | 11:08 am
- Enzon Stock Hits New 52-Week Low (ENZN) 07.27.11 | 10:07 am
- Enzon Stock Hits New 52-Week Low (ENZN) 06.17.11 | 04:06 pm
- 2 New Stock Picks From Baupost's Klarman 05.16.11 | 06:05 am
- Carl Icahn Bets Big on 23 Stocks 02.16.11 | 06:02 am
- Enzon Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript 05.10.10 | 11:05 pm
Press Releases for ENZN
- Enzon Announces Reduction In Force To Align Operations With Research And Development Activities - Business Wire 09.22.11 | 04:09 pm
- ENZON Names Ana I. Stancic Chief Financial Officer - Business Wire 05.31.11 | 06:05 am
- Enzon Announces Discontinuation Of PEG-SN38 Program In Metastatic Colorectal Carcinoma In Light Of Evolving Standards Of Care - Business Wire 05.19.11 | 06:05 am
- Enzon Reports 1st Quarter 2011 Results - Business Wire 05.06.11 | 08:05 am
- Enzon Presents Data At 2011 AACR Meeting - Business Wire 04.05.11 | 04:04 pm
- Enzon Appoints Richard Mulligan, Ph.D. Vice-Chairman Of The Board; Adopts Majority Vote Standard For Election Of Directors - Business Wire 03.17.11 | 04:03 pm
- Enzon Reports 2010 Results - Business Wire 02.17.11 | 04:02 pm
- Enzon To Release Fourth Quarter 2010 Earnings On Thursday, February 17, 2011; Conference Call And Webcast To Follow - Business Wire 02.10.11 | 07:02 am
- Enzon To Begin Phase 1 Study Of Novel Androgen Receptor MRNA Antagonist In Castration-Resistant Prostate Cancer - Business Wire 01.10.11 | 07:01 am
- Enzon Board Authorizes Share Repurchase Program - Business Wire 12.21.10 | 04:12 pm
Partner Headlines for ENZN
- 5 Biotech Stocks That Could Double - Seeking Alpha 02.01.12 | 07:02 am
- Billionaire Carl Icahn's Top Stock Picks And Portfolio Activity - Seeking Alpha 11.23.11 | 08:11 am
- Tracking Seth Klarman's Baupost Group Holdings - Seeking Alpha 10.18.11 | 09:10 am
- 11 Stocks Carl Icahn And Jim Simons Are Bullish On - Seeking Alpha 09.18.11 | 09:09 am
- 10 Profitable, Small Cap Stocks With Strong Growth And Bullish Trends - Seeking Alpha 08.22.11 | 08:08 am
- Weak Top Line Widens Enzon Loss - Analyst Blog - Zacks 08.09.11 | 10:08 am
- Weak Top Line Widens Enzon Loss - Analyst Blog - Zacks 08.09.11 | 10:08 am
- Seth Klarman's Favorite Stock Picks - Seeking Alpha 07.26.11 | 09:07 am
- Enzon Pharmaceuticals (ENZN) - Bear of the Day - Zacks 06.15.11 | 01:06 am
- Enzon Pharmaceuticals (ENZN) - Bear of the Day - Zacks 06.07.11 | 01:06 am
